data_1ip0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ip0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 120.823 0.344 . . . . 8.8000000000000007 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -139.06 -56.32 0.6 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.543 -0.723 . . . . 6.6600000000000001 110.219 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 71.84 0.1 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.358 -1.497 . . . . 2.21 109.358 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -103.1 66.07 0.89 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.657 -0.908 . . . . 4.8099999999999996 110.352 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -119.13 -157.48 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.368 -0.832 . . . . 1.1799999999999999 109.928 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -111.78 125.14 53.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 1.5600000000000001 109.971 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -79.84 141.22 36.39 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 4.1299999999999999 110.108 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 35.5 m -80.24 124.44 82.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.464 -0.773 . . . . 1.6000000000000001 110.237 -179.819 -77.784 157.572 -5.402 113.096 2.588 93.548 -98.114 159.537 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.23 156.5 37.6 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.899 1.473 . . . . 1.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -59.05 -33.33 70.65 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 3.8199999999999998 110.522 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -60.65 -32.9 72.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.609 -0.682 . . . . 3.5800000000000001 110.602 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.72 3.94 37.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 1.8400000000000001 111.34 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -90.39 53.42 2.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.106 -0.997 . . . . 2.0499999999999998 110.307 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -84.49 -18.3 36.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.989 -1.069 . . . . 2.2200000000000002 109.801 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -80.9 -11.36 59.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.661 . . . . 0.93999999999999995 109.836 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.9 m -145.42 114.62 7.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.918 . . . . 1.1200000000000001 110.079 179.795 -89.24 158.583 -133.768 100.455 2.569 137.439 -157.665 174.291 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.3 mm -72.08 -64.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 2.0099999999999998 109.944 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.65 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -103.87 54.21 0.74 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.262 -0.899 . . . . 2.2599999999999998 110.088 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.4 140.49 8.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.806 -1.318 . . . . 0.64000000000000001 109.806 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -89.48 -179.46 5.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.67 -0.9 . . . . 3.8300000000000001 110.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.005 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 t -158.41 139.25 12.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.28 -0.887 . . . . 1.0700000000000001 110.519 -179.939 159.537 -98.114 -5.402 93.548 2.588 113.096 157.572 -77.784 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.6 110.64 20.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.693 . . . . 3.6699999999999999 109.658 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -97.27 116.37 29.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.65000000000000002 109.959 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 50.8 t -86.92 117.71 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.469 -0.769 . . . . 1.26 109.11 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.3 t -79.76 -55.91 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.851 -0.531 . . . . 1.3300000000000001 110.973 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.54 -54.96 18.42 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.437 -0.79 . . . . 1.45 109.29 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.52 93.72 4.75 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.714 -1.217 . . . . 2.3500000000000001 107.714 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -38.45 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.2 0.524 . . . . 3.1099999999999999 111.892 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 94.1 m -147.11 84.87 7.15 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.539 -0.726 . . . . 1.29 110.411 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.4 Cg_endo -78.96 107.41 2.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.798 1.42 . . . . 0.80000000000000004 109.8 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 m -124.42 126.34 45.78 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 1.8799999999999999 110.752 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 1.029 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.5 t -105.05 128.09 53.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.512 -0.742 . . . . 1.8600000000000001 110.219 179.739 174.291 -157.665 -133.768 137.439 2.569 100.455 158.583 -89.24 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.73 113.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.626 -0.671 . . . . 1.4299999999999999 109.478 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 1.021 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 97.4 m -79.87 163.61 24.22 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.458 -0.776 . . . . 1.04 110.767 -179.604 -69.179 -116.197 26.53 116.63 2.57 133.307 -118.005 -44.116 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.15 132.77 54.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.579 -0.701 . . . . 1.5 110.187 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.21 -42.97 61.28 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.43 -0.794 . . . . 2.7400000000000002 111.334 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.6 41.33 2.86 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.736 -0.946 . . . . 0.84999999999999998 110.736 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CD2' ' HA ' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -110.12 168.42 9.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.109 -1.23 . . . . 1.1200000000000001 110.708 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 45' ' ' ARG . 96.3 mt -142.88 157.46 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.442 -0.786 . . . . 1.71 109.739 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.02 155.44 27.98 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.2 -1.16 . . . . 0.90000000000000002 110.2 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.45 -42.08 62.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.633 -0.922 . . . . 1.51 110.463 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -93.76 25.49 3.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.452 -0.78 . . . . 3.6200000000000001 110.46 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 1.021 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 8.4 m 56.74 55.17 6.52 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.633 -0.667 . . . . 0.93000000000000005 110.437 179.747 -44.116 -118.005 26.53 133.307 2.57 116.63 -116.197 -69.179 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.85 -48.91 3.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.321 -0.862 . . . . 2.5299999999999998 111.011 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 55.5 mtt-85 -79.78 171.14 15.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.384 -0.823 . . . . 3.4399999999999999 110.237 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.44 154.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 1.6100000000000001 110.88 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -113.71 39.13 2.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.739 -0.6 . . . . 1.73 110.103 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 109.22 2.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.318 -0.864 . . . . 3.8599999999999999 110.464 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -90.51 -56.76 3.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.496 -0.752 . . . . 7.9199999999999999 110.2 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.301 -0.857 . . . . 9.0199999999999996 110.284 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 120.823 0.344 . . . . 8.23 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -139.06 -56.32 0.6 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.543 -0.723 . . . . 6.34 110.219 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 71.84 0.1 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.358 -1.497 . . . . 2.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -103.1 66.07 0.89 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.657 -0.908 . . . . 4.05 110.352 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -119.13 -157.48 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.368 -0.832 . . . . 1.01 109.928 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -111.78 125.14 53.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 1.16 109.971 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -79.84 141.22 36.39 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 3.53 110.108 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 35.5 m -80.24 124.44 82.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.464 -0.773 . . . . 1.12 110.237 -179.819 -77.784 157.572 -5.402 113.096 2.588 93.548 -98.114 159.537 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.23 156.5 37.6 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.899 1.473 . . . . 0.92 110.853 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 24.5 mttt -59.05 -33.33 70.65 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 3.47 110.522 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -60.65 -32.9 72.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.609 -0.682 . . . . 2.94 110.602 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.72 3.94 37.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 1.61 111.34 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 29.0 mtpt -90.39 53.42 2.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.106 -0.997 . . . . 1.59 110.307 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -84.49 -18.3 36.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.989 -1.069 . . . . 1.38 109.801 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -80.9 -11.36 59.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.661 . . . . 0.5 109.836 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.9 m -145.42 114.62 7.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.918 . . . . 0.65 110.079 179.795 -89.24 158.583 -133.768 100.455 2.569 137.439 -157.665 174.291 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.3 mm -72.08 -64.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 1.44 109.944 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.679 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -103.87 54.21 0.74 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.262 -0.899 . . . . 1.77 110.088 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.4 140.49 8.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.806 -1.318 . . . . 0.64 109.806 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -89.48 -179.46 5.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.67 -0.9 . . . . 3.37 110.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 t -158.41 139.25 12.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.28 -0.887 . . . . 0.71 110.519 -179.939 159.537 -98.114 -5.402 93.548 2.588 113.096 157.572 -77.784 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.6 110.64 20.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.693 . . . . 3.1 109.658 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -97.27 116.37 29.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.59 109.959 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 50.8 t -86.92 117.71 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.469 -0.769 . . . . 0.65 109.11 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.3 t -79.76 -55.91 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.851 -0.531 . . . . 0.8 110.973 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.54 -54.96 18.42 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.437 -0.79 . . . . 0.89 109.29 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.52 93.72 4.75 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.714 -1.217 . . . . 2.35 107.714 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -38.45 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.2 0.524 . . . . 2.52 111.892 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 94.1 m -147.11 84.87 7.15 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.539 -0.726 . . . . 0.87 110.411 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.534 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.4 Cg_endo -78.96 107.41 2.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.798 1.42 . . . . 0.8 109.8 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 m -124.42 126.34 45.78 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 1.49 110.752 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.5 t -105.05 128.09 53.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.512 -0.742 . . . . 1.39 110.219 179.739 174.291 -157.665 -133.768 137.439 2.569 100.455 158.583 -89.24 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.73 113.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.626 -0.671 . . . . 0.83 109.478 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 97.4 m -79.87 163.61 24.22 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.458 -0.776 . . . . 0.61 110.767 -179.604 -69.179 -116.197 26.53 116.63 2.57 133.307 -118.005 -44.116 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.15 132.77 54.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.579 -0.701 . . . . 1.5 110.187 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.21 -42.97 61.28 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.43 -0.794 . . . . 2.74 111.334 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.6 41.33 2.86 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.736 -0.946 . . . . 0.77 110.736 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -110.12 168.42 9.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.109 -1.23 . . . . 0.59 110.708 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.445 HD11 ' OD1' ' A' ' 47' ' ' ASP . 96.3 mt -142.88 157.46 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.442 -0.786 . . . . 1.14 109.739 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.02 155.44 27.98 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.2 -1.16 . . . . 0.82 110.2 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.45 -42.08 62.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.633 -0.922 . . . . 1.03 110.463 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -93.76 25.49 3.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.452 -0.78 . . . . 3.04 110.46 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 8.4 m 56.74 55.17 6.52 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.633 -0.667 . . . . 0.57 110.437 179.747 -44.116 -118.005 26.53 133.307 2.57 116.63 -116.197 -69.179 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.85 -48.91 3.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.321 -0.862 . . . . 2.53 111.011 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 55.5 mtt-85 -79.78 171.14 15.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.384 -0.823 . . . . 2.88 110.237 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.44 154.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 1.05 110.88 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 39' ' ' ILE . 1.9 t70 -113.71 39.13 2.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.739 -0.6 . . . . 1.73 110.103 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 109.22 2.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.318 -0.864 . . . . 3.39 110.464 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -90.51 -56.76 3.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.496 -0.752 . . . . 6.99 110.2 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.301 -0.857 . . . . 8.73 110.284 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 120.823 0.344 . . . . 8.23 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -139.06 -56.32 0.6 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.543 -0.723 . . . . 6.34 110.219 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.83 71.84 0.1 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.358 -1.497 . . . . 2.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -103.1 66.07 0.89 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.657 -0.908 . . . . 4.05 110.352 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -119.13 -157.48 0.69 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.368 -0.832 . . . . 1.01 109.928 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.5 m -111.78 125.14 53.68 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 1.16 109.971 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -79.84 141.22 36.39 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.638 -0.664 . . . . 3.53 110.108 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 35.5 m -80.24 124.44 82.64 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.464 -0.773 . . . . 1.12 110.237 -179.819 -77.784 157.572 -5.402 113.096 2.588 93.548 -98.114 159.537 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.23 156.5 37.6 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.899 1.473 . . . . 0.92 110.853 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 24.5 mttt -59.05 -33.33 70.65 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.632 -0.667 . . . . 3.47 110.522 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -60.65 -32.9 72.06 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.609 -0.682 . . . . 2.94 110.602 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -102.72 3.94 37.52 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.83 . . . . 1.61 111.34 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 10' ' ' LYS . 29.0 mtpt -90.39 53.42 2.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.106 -0.997 . . . . 1.59 110.307 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -84.49 -18.3 36.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.989 -1.069 . . . . 1.38 109.801 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -80.9 -11.36 59.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.661 . . . . 0.5 109.836 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 32' ' ' CYS . 1.9 m -145.42 114.62 7.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.918 . . . . 0.65 110.079 179.795 -89.24 158.583 -133.768 100.455 2.569 137.439 -157.665 174.291 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 43' ' ' CYS . 24.3 mm -72.08 -64.79 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.482 -0.761 . . . . 1.44 109.944 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.679 ' HG2' ' HB3' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -103.87 54.21 0.74 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.262 -0.899 . . . . 1.77 110.088 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 34' ' ' CYS . . . -150.4 140.49 8.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.806 -1.318 . . . . 0.64 109.806 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -89.48 -179.46 5.82 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.67 -0.9 . . . . 3.37 110.075 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 t -158.41 139.25 12.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.28 -0.887 . . . . 0.71 110.519 -179.939 159.537 -98.114 -5.402 93.548 2.588 113.096 157.572 -77.784 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -113.6 110.64 20.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.59 -0.693 . . . . 3.1 109.658 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 30' ' ' PRO . 1.2 t80 -97.27 116.37 29.36 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.53 -0.731 . . . . 0.59 109.959 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 50.8 t -86.92 117.71 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.469 -0.769 . . . . 0.65 109.11 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.3 t -79.76 -55.91 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.851 -0.531 . . . . 0.8 110.973 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.54 -54.96 18.42 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.437 -0.79 . . . . 0.89 109.29 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -106.52 93.72 4.75 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.714 -1.217 . . . . 2.35 107.714 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -38.45 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.2 0.524 . . . . 2.52 111.892 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.581 ' HB ' ' HB ' ' A' ' 24' ' ' VAL . 94.1 m -147.11 84.87 7.15 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.539 -0.726 . . . . 0.87 110.411 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.534 ' HB3' ' CE2' ' A' ' 23' ' ' PHE . 48.4 Cg_endo -78.96 107.41 2.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.798 1.42 . . . . 0.8 109.8 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 m -124.42 126.34 45.78 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.359 -0.838 . . . . 1.49 110.752 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 36.5 t -105.05 128.09 53.17 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.512 -0.742 . . . . 1.39 110.219 179.739 174.291 -157.665 -133.768 137.439 2.569 100.455 158.583 -89.24 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.73 113.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.626 -0.671 . . . . 0.83 109.478 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 97.4 m -79.87 163.61 24.22 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.458 -0.776 . . . . 0.61 110.767 -179.604 -69.179 -116.197 26.53 116.63 2.57 133.307 -118.005 -44.116 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.15 132.77 54.96 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.579 -0.701 . . . . 1.5 110.187 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.21 -42.97 61.28 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.43 -0.794 . . . . 2.74 111.334 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.6 41.33 2.86 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.736 -0.946 . . . . 0.77 110.736 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' A' ' 43' ' ' CYS . 0.3 OUTLIER -110.12 168.42 9.44 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.109 -1.23 . . . . 0.59 110.708 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.445 HD11 ' OD1' ' A' ' 47' ' ' ASP . 96.3 mt -142.88 157.46 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.442 -0.786 . . . . 1.14 109.739 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.02 155.44 27.98 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 110.2 -1.16 . . . . 0.82 110.2 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.45 -42.08 62.4 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.633 -0.922 . . . . 1.03 110.463 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -93.76 25.49 3.56 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.452 -0.78 . . . . 3.04 110.46 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 8.4 m 56.74 55.17 6.52 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.633 -0.667 . . . . 0.57 110.437 179.747 -44.116 -118.005 26.53 133.307 2.57 116.63 -116.197 -69.179 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.85 -48.91 3.63 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.321 -0.862 . . . . 2.53 111.011 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.429 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 55.5 mtt-85 -79.78 171.14 15.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.384 -0.823 . . . . 2.88 110.237 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.44 154.19 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 1.05 110.88 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 39' ' ' ILE . 1.9 t70 -113.71 39.13 2.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.739 -0.6 . . . . 1.73 110.103 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.33 109.22 2.15 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.318 -0.864 . . . . 3.39 110.464 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -90.51 -56.76 3.07 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.496 -0.752 . . . . 6.99 110.2 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 118.301 -0.857 . . . . 8.73 110.284 179.874 . . . . . . . . 0 0 . 1 stop_ save_